INTERIM RESULTS OF A PHASE II STUDY OF FONDAZIONE ITALIANA LINFOMI ON GEMCITABINE PLUS ROMIDEPSIN IN RELAPSED/REFRACTORY PERIPHERAL T CELL LYMPHOMA PATIENTS

被引：0
|
作者：
Pellegrini, C. [1 ]
Broccoli, A. [1 ]
Casadei, B. [1 ]
Chiappella, A. [2 ]
Corradini, P. [3 ]
Derenzini, E. [1 ]
Dodero, A. [3 ]
Farina, L. [3 ]
Gandolfi, L. [1 ]
Ladetto, M. [4 ]
Monaco, F. [4 ]
Orsucci, L. [2 ]
Quirini, F. [1 ]
Salvi, F. [4 ]
Spina, F. [3 ]
Stefoni, V. [1 ]
Tonialini, L. [1 ]
Vitolo, U. [2 ]
Argnani, L. [1 ]
Cavo, M. [1 ]
Zinzani, P. L. [1 ]
机构：
[1] Univ Bologna, Inst Hematol L & A Seragnoli, Bologna, Italy
[2] Azienda Osped Univ Citta Salute & Sci Torino, Hematol, Turin, Italy
[3] Fdn IRCCS Ist Nazl Tumori, Hematol, Milan, Italy
[4] SS Antonio & Biagio Hosp Alessandria, Hematol, Alessandria, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C029
引用
收藏
页码：18 / 19
页数：2
相关论文
共 50 条
  • [21] Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi
    Merli, Francesco
    Cavallo, Federica
    Salvi, Flavia
    Tucci, Alessandra
    Musuraca, Gerardo
    Nassi, Luca
    Merli, Michele
    Tani, Monica
    Gini, Guido
    Ferrari, Angela
    Molinari, Anna Lia
    Liberati, Anna Marina
    Conconi, Annarita
    Matteucci, Paola
    Bari, Alessia
    Scalone, Renato
    Ferrero, Simone
    Zanni, Manuela
    Mammi, Caterina
    Luminari, Stefano
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (01) : 37 - 40
  • [22] Results of a Phase 2 NCI Multicenter Study of Romidepsin in Patients with Relapsed Peripheral T-Cell Lymphoma (PTCL)
    Piekarz, Richard
    Wright, John
    Frye, Robin
    Allen, Steven L.
    Craig, Michael
    Geskin, Larisa
    Hutchins, Laura
    Joske, David
    Kirschbaum, Mark
    Leonard, John P.
    Prince, Miles
    Reeder, Craig B.
    Jaffe, Elaine
    Bates, Susan
    BLOOD, 2008, 112 (11) : 555 - 556
  • [23] A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
    Strati, Paolo
    Chihara, Dai
    Oki, Yasuhiro
    Fayad, Luis E.
    Fowler, Nathan
    Nastoupil, Loretta
    Romaguera, Jorge E.
    Samaniego, Felipe
    Garg, Naveen
    Feng, Lei
    Wesson, Emily T.
    Ruben, Charnelle E.
    Stafford, Mildred D.
    Nieto, Yago
    Khouri, Issa F.
    Hosing, Chitra
    Horowitz, Sandra B.
    T-Kamble, Rammurti
    Fanale, Michelle A.
    HAEMATOLOGICA, 2018, 103 (09) : E416 - E418
  • [24] The Combination of Weekly Infusion of Rituximab and Bortezomib Is Effective in Relapsed or Refractory Indolent and Mantle Cell Lymphoma: Long-Term Results of Phase II BRIL06 Study of the Fondazione Italiana Linfomi (FIL)
    Chiappella, Annalisa
    Pregno, Patrizia
    Zinzani, Pier Luigi
    De Renzo, Amalia
    Evangelista, Andrea
    Fabbri, Alberto
    Ferreri, Andres J. M.
    Franceschetti, Silvia
    Freilone, Roberto
    Liberati, Anna Marina
    Martelli, Maurizio
    Novero, Domenico
    Orsucci, Lorella
    Rota-Scalabrini, Delia
    Rigacci, Luigi
    Rusconi, Chiara
    Specchia, Giorgina
    Stefoni, Vittorio
    Tucci, Alessandra
    Zaja, Francesco
    Vitolo, Umberto
    BLOOD, 2015, 126 (23)
  • [25] Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma
    Foss, Francine
    Pro, Barbara
    Miles Prince, H.
    Sokol, Lubomir
    Caballero, Dolores
    Horwitz, Steven
    Coiffier, Bertrand
    CANCER MEDICINE, 2017, 6 (01): : 36 - 44
  • [26] Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial
    Ladetto, M.
    Tavarozzi, R.
    Zanni, M.
    Evangelista, A.
    Ferrero, S.
    Tucci, A.
    Botto, B.
    Bolis, S.
    Volpetti, S.
    Zilioli, V. R.
    Puccini, B.
    Arcari, A.
    Pavone, V.
    Gaidano, G.
    Corradini, P.
    Tani, M.
    Cavallo, F.
    Milone, G.
    Ghiggi, C.
    Pinto, A.
    Pastore, D.
    Ferreri, A. J. M.
    Latte, G.
    Patti, C.
    Re, F.
    Benedetti, F.
    Luminari, S.
    Pennese, E.
    Bossi, E.
    Boccomini, C.
    Anastasia, A.
    Bottelli, C.
    Ciccone, G.
    Vitolo, U.
    ANNALS OF ONCOLOGY, 2024, 35 (01) : 118 - 129
  • [27] Treatment of Relapsed/Refractory Waldenstrom Macroglobulinemia Patients: Final Clinical and Molecular Results of the Phase II Brb (Bendamustine, Rituximab and Bortezomib) Trial of the Fondazione Italiana Linfomi (FIL)
    Benevolo, Giulia
    Ferrero, Simone
    Villiva, Nicoletta
    Castiglione, Anna
    Monaco, Federico
    Boccomini, Carola
    Cabras, Maria Giuseppina
    Califano, Catello
    Casula, Paolo
    Cavallo, Federica
    Conconi, Annarita
    Drandi, Daniela
    Gaidano, Gianluca
    Gregorini, Anna Ines
    Felici, Stefano
    Ferrante, Martina
    Mannina, Donato
    Molinari, Anna Lia
    Musto, Pellegrino
    Musuraca, Gerardo
    Merli, Michele
    Sartori, Roberto
    Tani, Monica
    Varettoni, Marzia
    Vitolo, Umberto
    Orsucci, Lorella
    BLOOD, 2021, 138
  • [28] Phase II Trial of Romidepsin as Consolidation Therapy after Gemcitabine, Dexamethasone, and Cisplatin in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma
    Yamasaki, Satoshi
    Iida, Hiroatsu
    Saito, Akio
    Matsumoto, Morio
    Kuroda, Yoshiaki
    Izumi, Tohru
    Saito, Akiko M.
    Miyoshi, Hiroaki
    Ohshima, Koichi
    Nagai, Hirokazu
    Iwasaki, Hiromi
    HEMATOLOGY REPORTS, 2024, 16 (02) : 336 - 346
  • [29] Phase II Trial Using Romidepsin after Gemcitabine, Dexamethasone, and Cisplatin Therapy in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Study Protocol
    Yamasaki, Satoshi
    Kada, Akiko
    Nagai, Hirokazu
    Yoshida, Isao
    Choi, Ilseung
    Saito, Akiko M.
    Iwasaki, Hiromi
    ACTA MEDICA OKAYAMA, 2019, 73 (05) : 469 - 474
  • [30] Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma
    Foss F.
    Coiffier B.
    Horwitz S.
    Pro B.
    Prince H.M.
    Sokol L.
    Greenwood M.
    Lerner A.
    Caballero D.
    Baran E.
    Kim E.
    Nichols J.
    Balser B.
    Wolfson J.
    Whittaker S.
    Biomarker Research, 2 (1)
12345